These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 18753950

  • 1. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 2. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE, Long KM, Lees SE.
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [Abstract] [Full Text] [Related]

  • 3. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS, Prieve BA.
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [Abstract] [Full Text] [Related]

  • 4. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S.
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [Abstract] [Full Text] [Related]

  • 5. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
    Dille MF, McMillan GP, Reavis KM, Jacobs P, Fausti SA, Konrad-Martin D.
    J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
    [Abstract] [Full Text] [Related]

  • 6. Distortion-product otoacoustic emission test performance for ototoxicity monitoring.
    Reavis KM, McMillan G, Austin D, Gallun F, Fausti SA, Gordon JS, Helt WJ, Konrad-Martin D.
    Ear Hear; 2011 Feb; 32(1):61-74. PubMed ID: 20625302
    [Abstract] [Full Text] [Related]

  • 7. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M.
    Otolaryngol Pol; 2006 Feb; 60(3):415-20. PubMed ID: 16989457
    [Abstract] [Full Text] [Related]

  • 8. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR, Kraemer DF, Winter C, Neuwelt EA.
    J Clin Oncol; 2007 Apr 01; 25(10):1190-5. PubMed ID: 17401008
    [Abstract] [Full Text] [Related]

  • 9. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W, Heppelmann G, Vonthein R, Zenner HP.
    Ear Hear; 2008 Jun 01; 29(3):378-91. PubMed ID: 18382378
    [Abstract] [Full Text] [Related]

  • 10. Changes in distortion product otoacoustic emissions from ears with Menière's disease.
    Kusuki M, Sakashita T, Kubo T, Kyunai K, Ueno K, Hikawa C, Wada T, Nakai Y.
    Acta Otolaryngol Suppl; 1998 Jun 01; 538():78-89. PubMed ID: 9879406
    [Abstract] [Full Text] [Related]

  • 11. Otoacoustic detection of risk of early hearing loss in ears with normal audiograms: a 3-year follow-up study.
    Job A, Raynal M, Kossowski M, Studler M, Ghernaouti C, Baffioni-Venturi A, Roux A, Darolles C, Guelorget A.
    Hear Res; 2009 May 01; 251(1-2):10-6. PubMed ID: 19249340
    [Abstract] [Full Text] [Related]

  • 12. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H, Stephan K, Böheim K, Welzl-Müller K.
    HNO; 1995 Jan 01; 43(1):19-24. PubMed ID: 7890546
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM, Feeney MP, Gates GA.
    Ear Hear; 2007 Dec 01; 28(6):778-92. PubMed ID: 17982366
    [Abstract] [Full Text] [Related]

  • 14. Fine alterations of distortion-product otoacoustic emissions after moderate acoustic overexposure in guinea pigs.
    Kossowski M, Mom T, Guitton M, Poncet JL, Bonfils P, Avan P.
    Audiology; 2001 Dec 01; 40(3):113-22. PubMed ID: 11465293
    [Abstract] [Full Text] [Related]

  • 15. Distortion product otoacoustic emissions and tympanometric measurements in an adult population-based study.
    Uchida Y, Ando F, Nakata S, Ueda H, Nakashima T, Niino N, Shimokata H.
    Auris Nasus Larynx; 2006 Dec 01; 33(4):397-401. PubMed ID: 16753276
    [Abstract] [Full Text] [Related]

  • 16. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS, Balatsouras DG, Tzagaroulakis A, Kandiloros D, Ferekidou E, Korres S.
    Noise Health; 2009 Dec 01; 11(43):103-10. PubMed ID: 19414930
    [Abstract] [Full Text] [Related]

  • 17. Distortion product otoacoustic emission response characteristics in older adults.
    Torre P, Cruickshanks KJ, Nondahl DM, Wiley TL.
    Ear Hear; 2003 Feb 01; 24(1):20-9. PubMed ID: 12598810
    [Abstract] [Full Text] [Related]

  • 18. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL, Abouchacra KS, Zeki Al Hazzouri AG, Zaytoun G.
    Ear Hear; 2008 Jun 01; 29(3):360-77. PubMed ID: 18382377
    [Abstract] [Full Text] [Related]

  • 19. [The clinical use of oto-acoustic emissions of cochlear distortion products].
    Hauser R, Probst R, Harris FP.
    Laryngorhinootologie; 1991 Mar 01; 70(3):123-31. PubMed ID: 2036146
    [Abstract] [Full Text] [Related]

  • 20. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM.
    Int J Audiol; 2006 Jun 01; 45(6):337-43. PubMed ID: 16777780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.